Watson takes its top five place in generics.
- Published in:
- Australian Journal of Pharmacy, 2012, v. 93, n. 1102, p. 50
- Publication type:
- Article
Works matching DE "WATSON Pharmaceuticals Inc. (1983-2012)"
Results: 22
1
2
New products & Services.
- Published in:
- 2010
- Publication type:
- Product Review
3
Topical OAB gel found well tolerated, effective.
- Published in:
- Urology Times, 2009, v. 37, n. 8, p. 12
- By:
- Publication type:
- Article
4
New Products & Services.
- Published in:
- Urology Times, 2005, v. 33, n. 5, p. 50
- Publication type:
- Article
5
Web-based coding tool now free to AUA members.
- Published in:
- Urology Times, 2005, v. 33, n. 5, p. 4
- By:
- Publication type:
- Article
6
Bayer Healthcare Pharmaceuticals, Inc. v. Watson Pharmaceuticals, Inc.: Was the decision to selectively present evidence of commercial success too “clever by half”?
- Published in:
- 2013
- By:
- Publication type:
- Case Study
7
Supreme court to resolve legality of ‘reverse payment’ settlement agreements between brand-name drug manufacturers and generic competitors.
- Published in:
- Journal of Generic Medicines, 2013, v. 10, n. 1, p. 39, doi. 10.1177/1741134313476080
- By:
- Publication type:
- Article
8
Companies, technology & environment.
- Published in:
- Chemistry & Industry, 2010, n. 1, p. 13
- By:
- Publication type:
- Article
9
FTC V. WATSON PHARMACEUTICALS 677 F.3D 1298 (11TH CIR. 2012).
- Published in:
- DePaul Journal of Art, Technology & Intellectual Property Law, 2013, v. 23, n. 2, p. 491
- By:
- Publication type:
- Article
10
First-time generic approvals.
- Published in:
- Formulary, 2006, v. 41, n. 11, p. 556
- Publication type:
- Article
11
Drug Patent Settlements Around the World.
- Published in:
- Antitrust Bulletin, 2017, v. 62, n. 4, p. 770, doi. 10.1177/0003603X17733357
- By:
- Publication type:
- Article
12
Taking antitrust to patent school: The instance of pay-for-delay settlements.
- Published in:
- 2013
- By:
- Publication type:
- Essay
13
Inevitable Imbalance: Why FTC v. Actavis Was Inadequate to Solve the Reverse Payment Settlement Problem and Proposing a New Amendment to the Hatch-Waxman Act.
- Published in:
- Seattle University Law Review, 2014, v. 37, n. 3, p. 1059
- By:
- Publication type:
- Article
14
NEW Products.
- Published in:
- 2008
- Publication type:
- Product Review
15
Welcome new ASCPT Members.
- Published in:
- Clinical Pharmacology & Therapeutics, 2006, v. 79, n. 4, p. 397, doi. 10.1016/j.clpt.2006.02.001
- Publication type:
- Article
16
First-time generic approvals.
- Published in:
- Formulary, 2006, v. 41, n. 5, p. 213
- Publication type:
- Article
17
Ulipristal approved for emergency contraception.
- Published in:
- American Journal of Health-System Pharmacy, 2010, v. 67, n. 19/20, p. 1580, doi. 10.2146/news100066
- By:
- Publication type:
- Article
18
New drugs and dosage forms.
- Published in:
- 2009
- Publication type:
- Product Review
19
New drugs and dosage forms.
- Published in:
- 2008
- Publication type:
- Product Review
20
News Briefs.
- Published in:
- American Journal of Health-System Pharmacy, 2006, v. 63, n. 24, p. 2442
- Publication type:
- Article
21
Transdermal Oxybutynin (Oxytrol) for Urinary Incontinence.
- Published in:
- American Family Physician, 2004, v. 70, n. 12, p. 2351
- By:
- Publication type:
- Article
22
A PHARMACEUTICAL PARK PLACE: WHY THE SUPREME COURT SHOULD MODIFY THE SCOPE OF THE PATENT TEST FOR REVERSE PAYMENT DEALS.
- Published in:
- Journal of Intellectual Property Law, 2013, v. 20, n. 2, p. 315
- By:
- Publication type:
- Article